U.S. FDA Grants Full Approval to Pfizer’s COVID-19 Vaccine

U.S. FDA Grants Full Approval to Pfizer’s COVID-19 Vaccine

The U.S. FDA has granted full approval to Pfizer’s COVID-19 vaccine. Full approval has been given for people 16 years of age and older. Pfizer’s shot still has emergency authorization for 12 to 15-year-olds.

The FDA’s approval of the Pfizer vaccine is an exciting milestone as we continue to battle the COVID-19 pandemic. Pfizer’s COVID-19 vaccine is the first COVID-19 vaccine to meet the FDA’s rigorous, scientific standards for emergency use authorization. This reaffirms to the public that this vaccine has met the high standards for safety, effectiveness, and manufacturing quality the FDA requires of an approved product. With the more dangerous and more transmissible Delta variant continuing to cause surges in cases and hospitalizations, and threatening the lives of Maine people, there is no time to waste in getting vaccinated.

COVID-19 vaccines are available at no charge at sites across the state. For information on getting a vaccine, please visit http://www.Maine.gov/covid19/vaccines or call the Community Vaccination Line at 1-888-445-4111.